Strong Hepatitis C Virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children

Journal of Infectious Diseases

Volumn 203, Issue 6, 2011, Pages 854-861

  Hashem, Mohamed ^a,c   El Karaksy, Hanaa ^d   Shata, Mohamed T ^b   Sobhy, Maha ^c   Helmy, Heba ^d   El Naghi, Suzan ^e   Galal, Gehan ^c   Ali, Zainab Z ^c   Esmat, Gamal ^d   Abdelwahab, Sayed F ^c,f   Strickland, G Thomas ^a   El Kamary, Samer S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Holding Company for Biological Products and Vaccines   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

^e NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

^f Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELL VIABILITY; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SECRETORY CELL; SERODIAGNOSIS; SIBLING; VIREMIA;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; EGYPT; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIBLINGS;

EID: 79952330550     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq123     Document Type: Article

References (37)

1. Scognamiglio P, Accapezzato D, Casciaro MA, et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 1999; 162:6681-9. (Pubitemid 29309393)
2. Koziel MJ, Wong DK, Dudley D, Houghton M,Walker BD. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 1997; 176:859-66. (Pubitemid 27411026)
3. Bronowicki JP, Vetter D, Uhl G, et al. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 1997; 176:518-22. (Pubitemid 27328779)
4. Al-Sherbiny M, Osman A, Mohamed N, et al. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 2005; 73:44-9. (Pubitemid 41278744)
5. Della Bella S, Riva A, Tanzi E, et al. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women. J Hepatol 2005; 43:394-402. (Pubitemid 41111419)
6. El-Kamary S, Hashem M, Saleh D, et al. Clearance of hepatitis C viremia in children born to, and living with, HCV-infected mothers is associated with long-lasting HCV-specific cell mediated immune responses [Abstract 10, Poster 109]. In: 13th International Symposium on Viral Hepatitis and Liver Disease. Washington, DC, 2009.
7. Post JJ, Pan Y, Freeman AJ, et al. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis 2004; 189:1846-55. (Pubitemid 38657221)
8. Freeman AJ, French RA, Post JJ, et al. Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J Infect Dis 2004; 190:1093-7.
9. Mizukoshi E, Eisenbach C, Edlin BR, et al. Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis 2008; 198:203-12. (Pubitemid 352019285)
10. Zeremski M, Shu MA, Brown Q, et al. Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat 2009; 16:10-20.
11. Shata MT, Tricoche N, Perkus M, et al. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 2003; 314:601-16. (Pubitemid 37209981)
12. Abdel-Aziz F, Habib M, Mohamed MK, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32:111-5. (Pubitemid 30432374)
13. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001; 33:248-53. (Pubitemid 32016908)
14. Hashem M, El-Karaksy H, El-Naghi S, et al. Epidemiological, virological characteristics and disease progression of hepatitis C virus (HCV)-infection in Egyptian children. In:15th International Symposium on Hepatitis C Virus and Related Viruses. San Antonio, Texas, 2008.
15. Shata MT, Barrett A, Shire NJ, et al. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. J Immunol Methods 2007; 328:152-61. (Pubitemid 350007626)
16. Mayer S, Laumer M, Mackensen A, Andreesen R, Krause SW. Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. Immunobiology 2002; 205:282-9. (Pubitemid 34846737)
17. Lauer GM, Ouchi K, Chung RT, et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 2002; 76:6104-3.
18. Cox AL, Netski DM, Mosbruger T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005; 40:951-8. (Pubitemid 40418300)
19. Chang KM, Thimme R, Melpolder JJ, et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33:267-76. (Pubitemid 32016910)
20. Ciurea A, Hunziker L, Klenerman P, Hengartner H, Zinkernagel RM. Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants. J Exp Med 2001; 193:297-305. (Pubitemid 32524513)
21. Day CL, Lauer GM, Robbins GK, et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 2002; 76:12584-95. (Pubitemid 35386944)
22. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346:1006-7.
23. Gerlach JT, Diepolder HM, Jung MC, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999; 117:933-41. (Pubitemid 29468237)
24. Missale G, Bertoni R, Lamonaca V, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98:706-14. (Pubitemid 26349175)
25. Penna A, Missale G, Lamonaca V, et al. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology 2002; 35:1225-36. (Pubitemid 34454020)
26. Penna A, Pilli M, Zerbini A, et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007; 45:588-601. (Pubitemid 46450610)
27. Rosen HR, Miner C, Sasaki AW, et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002; 35:190-8. (Pubitemid 34032560)
28. Alimonti JB, Kimani J, Matu L, et al. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol 2006; 84:482-5. (Pubitemid 44286043)
29. Clerici M, Shearer GM. Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Immunol Lett 1996; 51:69-73. (Pubitemid 26227473)
30. Dittmer U, Spring M, Petry H, et al. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV). J Biotechnol 1996; 44:105-10. (Pubitemid 26056568)
31. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-51. (Pubitemid 26383775)
32. Kaul R, Rutherford J, Rowland-Jones SL, et al. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. AIDS 2004; 18:2087-9. (Pubitemid 39463364)
33. Zakaria S, Fouad R, Shaker O, et al. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin Infect Dis 2007; 44:e30-6.
34. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J Virol 2001; 75:11392-400. (Pubitemid 33063230)
35. Graham CS, Curry M, He Q, et al. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology 2004; 40:125-32. (Pubitemid 38868931)
36. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.. Nat Med 2000; 6:578-82. (Pubitemid 30305910)
37. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997; 3:1250-7. (Pubitemid 27508826)